학술논문
Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial
Document Type
Article
Author
Source
In The Lancet Haematology January 2024 11(1):e27-e37
Subject
Language
ISSN
2352-3026